The efficacy of intravenous Labetalol on pain controlling and anxiety during bone marrow aspiration and biopsy
Phase 2
Recruiting
- Conditions
- Bone Marrow Aspiration and Biopsy.
- Registration Number
- IRCT20191201045563N1
- Lead Sponsor
- Semnan University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 40
Inclusion Criteria
Age more than 18 years old
Definitive indication of bone marrow aspiration and biopsy
Exclusion Criteria
Unwillingness to participate in the study
Cardiovascular disease (Heart block, Arrhythmia)
Uncontrolled chronic obstructive pulmonary disease
Uncontrolled Asthma
Unstable hemodynamics especially hypotension, bradycardia
Consciousness disorder
Pregnancy and lactation
Bad physical conditions
Using analgesic agents for the past 24 hours
Elderly people with advanced systemic disease
Vertigo, headache, dyspnea, nausea before the procedure
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Pain intensity based on 10cm visual analogue scale(VAS). Timepoint: During the procedure, 5 minutes and one hour after the procedure. Method of measurement: 10cm visual analogue scale (VAS).
- Secondary Outcome Measures
Name Time Method Anxiety score. Timepoint: 30 minutes before starting the procedure and during the procedure. Method of measurement: Clinical Anxiety-Depression Self-Assessment Scale (HADS).;Amount of opioids used during the procedure and within 24 hours after the procedure. Timepoint: During the procedure, up to 24 hours after the procedure. Method of measurement: Record the amount of drug used in each patient.